The following Banking & Finance guidance note provides comprehensive and up to date legal information covering:
This year’s annual round-up reviews some of the most significant developments of 2017 and previews what is on the horizon for 2018. This includes the Prospectus Regulation (EU) 2017/1129, the new UK framework for insurance linked securities, central clearing and mandatory margining for OTC derivatives under the European Market Infrastructure Regulation (EU) 648/2012 (EMIR), the new EU regime for simple, transparent and standardised (STS) securitisation, position limits for commodity derivatives under the Markets in Financial Instruments Directive 2014/65/EU (MiFID II), the trading obligation for certain OTC derivatives under the Markets in Financial Instruments Regulation (EU) 600/2014 (MiFIR) and indirect clearing of OTC derivatives under EMIR and MiFIR. In 2018 the primary focus of derivatives lawyers will be on MiFID II and indirect clearing coming into effect. Also included are updates on LexisNexis®’s content, including news of exciting developments from the past year and what is coming up in the next 12 months.
Regulation (EU) 2017/1129 (the Prospectus Regulation) was published in the Official Journal of the European Union on 30 June 2017. The Prospectus Regulation came into force on 20 July 2017, although it will apply from 21 July 2019, apart from a few provisions which apply earlier.
The Prospectus Regulation repeals Directive 2003/71/EC (the Prospectus Directive)
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
0330 161 1234
To view our latest legal guidance content,sign-in to Lexis®PSL or register for a free trial.